Fulcrum
Fulcrum is betting its whole map stack on Esri, with a hard Google Maps cutoff on September 1.
A side-by-side editorial comparison of dbt Core and pharmaversesdtm — release velocity, themes, recent moves, and the top alternatives to consider.
dbt Fusion's second beta is adapter work: ClickHouse gets materializations, indexes, and catalogs
Fusion 2.0 is in its second beta, and the content has shifted from engine capability to adapter coverage. beta.2 is almost entirely ClickHouse — Dictionary materialization, index definitions, additional settings, a relation-scoped catalog macro that fixes --write-catalog, and a seed nullability fix — plus Entra bearer-token authentication for the Fabric adapter. Behind it sits the August 14 backport wave, which cut releases for 1.1 through 1.8 in a single day to deliver one deprecated-version warning.
pharmaversesdtm is the test-data layer every pharmaverse package now builds against.
The package ships example SDTM datasets and has grown one therapeutic area at a time — ophthalmology, oncology response criteria, vaccines, metabolic, neurology, and now lymphoma under Lugano 2014. Sibling packages keep moving their internal test data here, so its release notes double as a record of what the rest of the pharmaverse is building.
Fusion 2.0 is in its second beta, and the content has shifted from engine capability to adapter coverage. beta.2 is almost entirely ClickHouse — Dictionary materialization, index definitions, additional settings, a relation-scoped catalog macro that fixes --write-catalog, and a seed nullability fix — plus Entra bearer-token authentication for the Fabric adapter. Behind it sits the August 14 backport wave, which cut releases for 1.1 through 1.8 in a single day to deliver one deprecated-version warning.
The two ends of this project are pulling apart cleanly. Old branches are being prepared for retirement — a deprecation warning fanned across eight of them, Python 3.8 testing dropped from 1.4 through 1.6 — while Fusion accumulates the adapter breadth it needs to be a credible replacement. beta.1 proved the engine could bind without a catalog; beta.2 is the unglamorous follow-through of making a specific warehouse work properly.
Expect further beta releases filling in per-adapter gaps rather than new engine capability, and formal end-of-life notices for the branches that just took the deprecation warning.
The package ships example SDTM datasets and has grown one therapeutic area at a time — ophthalmology, oncology response criteria, vaccines, metabolic, neurology, and now lymphoma under Lugano 2014. Sibling packages keep moving their internal test data here, so its release notes double as a record of what the rest of the pharmaverse is building.
Two kinds of work alternate: adding domains and biomarkers for a new indication, and making the existing data easier to reach — CSV copies under inst/extdata for non-R programmers, a datasets preview vignette, reference pages categorised by therapeutic area, variable-by-variable breakdowns. Consistency fixes against CDISC terminology and SDTM guidelines run through every release.
New therapeutic areas will keep arriving in step with the admiral extension packages that need them; the neurology and metabolic datasets landed just ahead of admiralneuro and admiralmetabolic needing them, and lymphoma looks like the next in that sequence.
Other Analytics products tracked by Sparkpulse, ranked by recent ship velocity. Each card links to a full editorial trajectory and lets you pivot into a head-to-head comparison with either dbt Core or pharmaversesdtm.
Fulcrum is betting its whole map stack on Esri, with a hard Google Maps cutoff on September 1.
Holistics keeps fencing in the AI layer it spent the summer building.
Dovetail spent July opening doors to other tools and August making its own rooms easier to enter.
The 0.0.x train stops at CRAN: tulpa's engine ships to the ecosystem it already anchors.
AgencyAI got skills three weeks ago; everything since has been making them routine.
Interfaces gets the permissions layer it needed, one release after launching.
See all dbt Core alternatives → · See all pharmaversesdtm alternatives →
Latest ship moves from both products, interleaved chronologically. ⚡ = editorial spark.
They serve adjacent needs but don't currently overlap on shipped themes. dbt Core is currently shipping more aggressively (velocity 6.3 vs 0.0), with 0 editorial sparks in the last 30 days against 0. See the at-a-glance table above for a side-by-side breakdown of velocity, recent sparks, and editorial themes.
Sparkpulse doesn't pick a winner — we score release velocity, not feature parity. dbt Core is currently shipping more aggressively (velocity 6.3 vs 0.0), with 0 editorial sparks in the last 30 days against 0. For your specific use case, the alternatives sections above list other Analytics products to evaluate alongside.
Top dbt Core alternatives in Analytics are ranked by recent ship velocity. Browse the "dbt Core alternatives" section above for the current picks, or visit /alternatives/dbt-core for the full list with editorial commentary on each.
Top pharmaversesdtm alternatives in Analytics are ranked by recent ship velocity. Browse the "pharmaversesdtm alternatives" section above for the current picks, or visit /alternatives/pharmaversesdtm for the full list with editorial commentary on each.